Fibrosis Prevention: By clearing fat from the liver cells (hepatocytes), Retatrutide may prevent the progression to MASH (Steatohepatitis) and eventual cirrhosis, potentially reducing the need for liver transplants in the future
Both Wegovy and Ozempic contain semaglutide, but they are licensed for different indications Wegovy is specifically approved for weight management at a maintenance dose of 2.4 mg weekly, while Ozempic is licensed for type 2 diabetes at doses up to 2 mg weekly
A 5-unit air bubble in a 25-unit draw means you are only injecting 20 units of actual solution
Advise patients that substantial or rapid weight loss can increase the risk of gallbladder disease, but that gallbladder disease may also occur in the absence of substantial or rapid weight loss
[DOI] [PMC free article] [PubMed] [Google Scholar] 13.Scirica B.M., Lincoff A.M., Lingvay I., Bogdanski P., Buscemi S., Colhoun H., Craciun A.E., Ezhov M., Hardt-Lindberg S., Kleist Jeppesen O., et al
But remember: Mounjaro has significantly more evidence base, while Retatrutide data is based on smaller studies
